Modulated nucleoside kinases as tools to improve the activation of therapeutic nucleoside analogues

Area of Science:

• Biochemistry
• Pharmacology
• Molecular Biology

Background:

• Nucleoside analogues are crucial in anticancer and antiviral treatments.
• Their therapeutic efficacy is frequently hindered by slow intracellular activation.
• This slow activation is primarily due to rate-limiting enzymes in the drug metabolism pathway.

Purpose of the Study:

• To explore strategies for enhancing the intracellular activation of nucleoside analogues.
• To investigate the role of modulating rate-limiting enzymes in improving drug effectiveness.
• To propose novel therapeutic approaches combining optimized enzymes with existing nucleoside drugs.

Main Methods:

• Enzyme kinetics analysis of rate-limiting enzymes in nucleoside analogue activation pathways.
• In vitro and in vivo studies to assess the impact of enzyme modulation on drug activation.
• Development and testing of combination therapies involving modified enzymes and nucleoside analogues.

Main Results:

• Identification of key rate-limiting enzymes responsible for slow nucleoside analogue activation.
• Demonstration that modulation of these enzymes significantly accelerates intracellular drug activation.
• Evidence of enhanced cytotoxic or antiviral activity of nucleoside analogues when combined with optimized activating enzymes.

Conclusions:

• Modulating rate-limiting enzymes is a viable strategy to overcome the limitations of nucleoside analogue therapies.
• Optimized activating enzymes combined with established nucleoside drugs offer a promising avenue for improved chemotherapy and antiviral treatments.
• This approach holds potential for enhancing patient outcomes in cancer and viral infections.